Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer"
- PMID: 33914452
- DOI: 10.1097/SLA.0000000000004877
Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer"
Conflict of interest statement
The authors report no conflicts of interest.
Comment in
-
Response to the Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer".Ann Surg. 2021 Dec 1;274(6):e899-e900. doi: 10.1097/SLA.0000000000004872. Ann Surg. 2021. PMID: 33914457 No abstract available.
Comment on
-
Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.Ann Surg. 2021 Jan 1;273(1):154-162. doi: 10.1097/SLA.0000000000003270. Ann Surg. 2021. PMID: 30921051
References
-
- Klaiber U, Schnaidt ES, Hinz U, et al. Prognostic factors of survival after neoadjuvant treatment and resection for initially unresectable pancreatic cancer. Ann Surg 2021; 273:154–162.
-
- Hackert T, Niesen W, Hinz U, et al. Radical surgery of oligometastatic pancreatic cancer. EJSO 2017; 43:358–363.
-
- Lindemann J, du Toit L, Kotze U, et al. Survival equivalence in patients treated for borderline resectable and unresectable locally advanced pancreatic ductal adenocarcinoma: a systematic review and network meta-analysis. HPB (Oxford) 2021; 23:173–186.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical